Skip to main content

Year: 2021

Akari Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Clinical Progress

Sites opened in Phase III study of nomacopan in bullous pemphigoid (BP) Phase III study of nomacopan in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) enrolling and treating patients New data reveal potential mechanism of action driving severe lung exacerbations and thus potential therapeutic role for nomacopan across lung disorders including COPD exacerbations and COVID-pneumonia PK data from ongoing evaluation of long-acting PAS-nomacopan for the treatment of dry age-related macular degeneration (geographic atrophy) including estimated injection frequency expected by the end of 2021 Recent data (1), highlights potential of LTB4 and C5 inhibition as a treatment for surface of the eye diseasesNEW YORK and LONDON, Dec. 03, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq:...

Continue reading

IES Holdings Reports Fiscal 2021 Fourth Quarter and Full Year Results

HOUSTON, Dec. 03, 2021 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter and fiscal year ended September 30, 2021. Fourth Quarter 2021 HighlightsRevenue of $484 million for the fourth quarter of fiscal 2021, an increase of 46% compared with $330 million for the fourth quarter of fiscal 2020 Operating income of $30.1 million for the fourth quarter of fiscal 2021, an increase of 109% compared with $14.4 million for the same quarter of fiscal 2020. Operating income for the fourth quarter of fiscal 2020 included a goodwill impairment charge of $7.0 million and executive severance charges of $1.8 million Net income attributable to IES increased 54% to $22.4 million for the fourth quarter of fiscal 2021, compared with $14.6 million for the same quarter...

Continue reading

Foresight Solar & Technology VCT plc – Offer Update

FORESIGHT SOLAR & TECHNOLOGY VCT PLC LEI: 21380013CXOR8N6OD977 Offer for Subscription: Update The Company announces that its current offer for subscription for new Foresight Williams Technology Shares, contained in a Prospectus published on 30 December 2020, will close on 16 December 2021. The Directors of the Company are pleased to announce that the Company intends to launch a new offer for subscription (the “Offer”) for the 2021/22 and 2022/23 tax years. Full details of the Offer will be contained in a new prospectus that is expected to be published in early January 2022. For further information please contact: Gary Fraser, Foresight Group: 0203 667 8181

Continue reading

BHP extends tender expiry and BHP and Noront extend outside date under Support Agreement

BHP continuing to progress discussions with Wyloo Metals TORONTO and MELBOURNE, Australia, Dec. 03, 2021 (GLOBE NEWSWIRE) — BHP Lonsdale Investments Pty Ltd (“BHP Lonsdale”), a wholly-owned subsidiary of BHP, announced today that it is progressing discussions with Wyloo Metals Pty Ltd (“Wyloo Metals”) regarding Wyloo Metals’ potential support of BHP’s C$0.75 per share offer (the “Offer”) to acquire Noront Resources Ltd. (TSXV:NOT) (“Noront”). To allow more time for those discussions to progress, BHP is extending the expiry of its offer from 7:00 p.m. (Toronto Time) on December 14, 2021 to 7:00 p.m. (Toronto Time) on January 14, 2022. The earliest time BHP will acquire Noront shares under its Offer will be at the new expiry time. In conjunction with the extension of the expiry time, BHP Lonsdale and Noront also announced that they...

Continue reading

Form 8.3 – [Clinigen Group plc – 02 12 2021] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CLINIGEN GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing undertaken:        For...

Continue reading

AirSculpt Technologies, Inc. Announces Third Quarter 2021 Results

MIAMI BEACH, Fla., Dec. 03, 2021 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2021.Cases increased 60.4% from prior year period to 2,743 cases Revenue increased 94.3% from prior year period to $34.7 millionSame-center revenue per case increased 20.3% from the prior year period Same-center cases increased 29.9% from the prior year periodNet income was $8.1 million as compared to the prior year period of $2.9 million Adjusted EBITDA increased to $12.1 million, growth of 127.2% over the prior year period Closed initial public offering and received net proceeds of $13.5 million after deducting underwriting fees and related offering expenses“We are very...

Continue reading

Notice to attend the Extraordinary General Meeting in Auriant Mining AB (publ.)

  The shareholders in Auriant Mining AB (publ.) (”Company” or “Auriant Mining”), 556659-4833, are hereby summoned to the Extraordinary General Meeting on Wednesday, December 22,  2021. The board of directors has decided that the Extraordinary General Meeting will be conducted by advance voting only in accordance with section 22 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations, without physical presence of shareholders, proxies and third parties. Auriant Mining welcomes all shareholders to exercise their voting rights at this Extraordinary General Meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the resolutions passed at the Extraordinary General Meeting will be published on 22...

Continue reading

So-Young Announces Engagement of Legal and Financial Advisors to the Special Committee

BEIJING, Dec. 03, 2021 (GLOBE NEWSWIRE) — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that the special committee (the “Special Committee”) of the Company’s board of directors (the “Board”) has retained Duff & Phelps, A Kroll Business operating as Kroll, LLC, as its independent financial advisor and Gibson, Dunn & Crutcher LLP as its independent U.S. legal counsel to assist the Special Committee in its evaluation and consideration of the previously announced preliminary non-binding proposal letter, dated November 22, 2021, from Mr. Xing Jin, co-founder, Chairman of the Board and Chief Executive Officer of the Company, to acquire all of...

Continue reading

Ambarella’s Capital Markets Day Investor Event to be Held January 4, 2022

Registration confirmation required for in-person attendance SANTA CLARA, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an AI vision silicon company, today announced it is hosting a Capital Markets Day and is providing registration information for both in-person attendance as well as a live webcast of the investor event. It will be held on Tuesday, January 4, 2022 from 1:00pm to 4:30pm (Pacific ) at Ambarella’s CES 2022 hotel location in Las Vegas. This event is designed for institutional investors and financial analysts, and will include product demonstrations as well as discussions on the company’s technology, growth strategies and markets. Senior executives will present and then answer questions from the in-person and online audiences. A reception will immediately follow the event. Registration for...

Continue reading

Prospect Ridge Resources Corp. To Commence Quotation on the US OTCQB® Venture Market

VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) — Prospect Ridge Resources Corp. (the “Company” or “Prospect“) (CSE: PRR) (OTC: PRRSF) (FRA: OED) is pleased to announce that its common shares have been approved for listing on the OTCQB® Venture Market (the “OTCQB“) and were quoted on the OTCQB on November 26, 2021 under the symbol “PRRSF”. The OTCQB is a U.S. trading platform operated by the OTC Markets Group in New York. The trading platform is specifically tailored for growing entrepreneurial companies in the United States and abroad. All qualified OTCQB trading companies must meet certain minimum standards, such as providing current financial reporting documents, and undergo an annual verification and management certification process. The OTCQB is recognized by the United States...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.